Mochi Health's standard model involves a clinician visit at intake and asynchronous messaging between follow-up appointments
Lifestyle factors play an equal or greater role in determining whether tirzepatide produces sustained weight loss or frustrating plateau and regain
Conditions, such as pregnancy, in which estradiol levels are high, are a high-risk time where susceptible women are more at risk of developing metabolic comorbidities such as obesity and gestational diabetes
Breakthrough for Cystic Fibrosis patients For people with cystic fibrosis (CF), the inclusion of ivacaftor and its therapeutic alternatives represents a major advance
or BMI 27 with prediabetes or specific cardiovascular conditions), be using the medication alongside structured nutrition and physical activity, and obtain prior authorization through their Part D plan
Clin Exp Med (2019) 19(1):4753